Table 3. In Vitro Inhibitory Activity of Compounds 1–17 toward Cholinesterases.
| cholinesterase
IC50 (μM)a |
|||||||
|---|---|---|---|---|---|---|---|
| compound | R1 | R2 | R3 | R4 | eeAChEb | eqBChEc | SId |
| 1 | H | H | H | H | 0.03 ± 0.00 | 68.78 ± 03.15 | 2,273 |
| 2 | Br | H | H | H | 2.56 ± 0.17 | 72.29 ± 04.57 | 28 |
| 3 | I | H | H | H | 14.12 ± 0.84 | 325.22 ± 38.63 | 23 |
| 4 | F | H | H | H | 1.23 ± 0.01 | 63.998 ± 03.63 | 52 |
| 5 | Me | H | H | H | 0.35 ± 0.02 | 486.03 ± 29.71 | 1,388 |
| 6 | Et | H | H | H | 0.57 ± 0.09 | 60.39 ± 02.54 | 105 |
| 7 | CN | H | H | H | 33.88 ± 1.95 | 1,050.88 ± 498.89 | 31 |
| 8 | NH2 | H | H | H | 0.32 ± 0.01 | 524.64 ± 41.56 | 1,634 |
| 9 | OH | H | H | H | 0.53 ± 0.09 | 154.76 ± 04.14 | 293 |
| 10 | OMe | H | H | H | 0.16 ± 0.02 | 599.15 ± 49.76 | 3,633 |
| 11 | OEt | H | H | H | 0.22 ± 0.04 | 253.02 ± 12.24 | 1,154 |
| 12 | OnPr | H | H | H | 10.19 ± 0.50 | 87.27 ± 01.37 | 9 |
| 13 | OnBu | H | H | H | 109.65 ± 9.59 | 16.91 ± 01.23 | 0.2 |
| 14 | H | H | 3.67 ± 0.28 | 903.66 ± 88.20 | 246 | ||
| 15 | Me | Me | n.i. | 1,348.75 ± 62.31 | |||
| 16 | Me | Me | Me | n.i. | 258.70 ± 10.81 | ||
| 17 | Me | Me | 0.61 ± 0.02 | 223.57 ± 47.78 | 366 | ||
| donepezile | 0.23 ± 0.05 | 18.00 ± 00.79 | 79 | ||||
Mean IC50 (μM) ± SEM, n = 3; n.i. = no inhibition.
AChE (EC 3.1.1.7) from electric eel.
BChE (EC 3.1.1.8) from horse serum.
Selectivity index for AChE is defined as IC50 (BChE)/IC50 (AChE).
Donepezil, a known selective AChE inhibitor used as a positive control.29
